Outcome of Board Meeting

Rainbow® Children's ~ BirthRighf Hospital ~ - BY RAINBOW HOSPITALS WOMEN CARE I CHILD CARE I FERTILITY July 30, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department, Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai - 400051. Dalal Street, Mumbai - 400001. Symbol: RAINBOW Scrip Code: 543524 Sub: Outcome of Board Meeting held on July 30, 2026. Dear Sir/ Madam, This is to inform that pursuant to Regulation 30 and 33 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the SEBI Listing Regulations”) and in furtherance to our letter dated July 22, 2026, please take note that the Board of Directors of the Company, in their meeting held today i.e., July 30, 2026, has inter-alia considered and approved the following matters: 1. Financial Results: The Unaudited Standalone and Consolidated Financial Results ("Financial Results") of the Company for the Quarter ended June 30, 2026. A copy of the signed Results along with Limited Review Report issued by the Statutory Auditors M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, are enclosed as Annexure – A. 2. Elevation of Mr. Anshuman Jaiswal to Chief Legal Officer and Designation as Senior Management Personnel (SMP): Pursuant to the recommendation of the Nomination and Remuneration Committee in their meeting held today i.e., July 30, 2026, the Board of Directors approved the elevation of Mr. Anshuman Jaiswal from the position of Group Head – Legal to Chief Legal Officer. Consequent to such elevation, the Board also designated him as a Senior Management Personnel (SMP) of the Company with immediate effect, in accordance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rainbow Children's Medicare Limited Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana CIN :L85110TG 1998PLC029914 Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL Rainbow® Children's ~ BirthRighf Hospital ~ - BY RAINBOW HOSPITALS WOMEN CARE I CHILD CARE I FERTILITY The requisite disclosure as per Regulation 30 of the SEBI Listing Regulations read with Schedule III thereto and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure – B. The Board Meeting commenced at 12:30 P.M and concluded at 4:00 P.M. This is for your information and record. Thanking You, Yours Faithfully, For Rainbow Children’s Medicare Limited Shreya Mitra Company Secretary and Compliance Officer Encl.: As above Rainbow Children's Medicare Limited Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana CIN :L85110TG 1998PLC029914 Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL Annexure A S.R. BATL/80/ & ASSOCIATES LLP THE SKYVIEW 10 18th Floor, "NORTH LOBBY" Survey No. 83/ 1, Raidurgam Chartered Accountants Hyderabad -500 032, India Tel : +91406141 6000 Independent Auditor's Review Report on the Quarterly Unaudited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Rainbow Children's Medicare Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of Rainbow Children's Medicare Limited (the "Company") for the quarter ended June 30, 2026 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). 2. The Company's Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Cha11ered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial infonnation consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards (' Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the infonnation required to be disclosed in tenns of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For S.R. BATLIBOI & ASSOCIATES LLP Chartered Accountants ICAI Firm registration number: IO I 049W/E300004 Partner r� Membership No.: 504777 UDIN: 2b50lf1'1lE0PVQQl.fg Place : Hyderabad Date: July 30, 2026 S.R. Batllboi & Associates LLP, a Limited liability Partnership with LLP Identity No. AAB-4295 Regd. Office: 22, Camac Street, Block 'B', 3rd Floor, Kolkata-700 016 Rainbow Children's Medicare Limited CTN: L85 11 0TG 1998PLC02991-1 Registered Office: 8-2-120/103/1, Survey No. -103, Road No.2, Banjara J-lills, Hyderabad, Tclangana-500034 Tel: +91404969 2244, e-mail: companysec.-ctary@rainbowhospitals.in Statement of Unaudited Standalone Financial Results for the quarter· ended 30 June 2026 (Rs. in Million except per share data Pa,·ticulars Qua,·ter ended Year ended 30 June 2026 31 March 2026 30 June 2025 3 I March 2026 Unaudited Audited Unaudited Audited I. Tn comc a. Revenue from operations 4,105.47 4.080.64 3.347.48 15,456.60 b. Other income 127.57 52.40 192.85 434.54 Total income 4,233.04 4,133.04 3,540.33 15,89.1.14 2. Expenses a. Cost of materials consumed 546.85 485.72 439.50 1,996.69 b. Employee benefits expense 599 08 566.16 492.36 2,123.93 c. Finance costs 192.49 185.24 173.93 713.96 cl. Depreciation and amortisation expense 376.26 356.52 325.93 1,362.61 e. Professional fees to doctors 1.087.30 986.19 867.81 3,770.65 f. Other expenses 725.65 753.21 552.60 2,566.76 Total expenses 3,527.63 3,333.04 2,852.13 12,534.60 3. Profit before exceptional items and tax I 1-21 705.41 800.00 688.20 3,356.54 4. Exceptional items - 15.39 - 15.39 5. P.-ofit before tax [Showing first 8,000 characters — download PDF for full document]